Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $90.00 price target on Tandem Diabetes Care (NASDAQ: TNDM), noting that UNH will formally cover the company's pump.

The analyst said this is a "clear positive for the name."

For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.

Shares of Tandem Diabetes Care closed at $87.81 yesterday.